中文名 | ML-210 |
英文名 | ML-210 |
别名 | 化合物ML-210 (4-(双(4-氯苯基)甲基)哌嗪-1-基)(5-甲基-4-硝基异恶唑-3-基)甲酮 |
英文别名 | ML 210 ML-210 CID 49766530 ML 210 - CID 49766530 (4-(Bis(4-chlorophenyl)methyl)piperazin-1-yl)(5-methyl-4-nitroisoxazol-3-yl)methanone [4-[Bis(4-chlorophenyl)methyl]-1-piperazinyl](5-methyl-4-nitro-3-isoxazolyl)methanone Methanone, [4-[bis(4-chlorophenyl)methyl]-1-piperazinyl](5-methyl-4-nitro-3-isoxazolyl)- [4-[Bis(4-chlorophenyl)methyl]piperazin-1-yl]-(5-methyl-4-nitro-1,2-oxazol-3-yl)methanone |
CAS | 1360705-96-9 |
化学式 | C22H20Cl2N4O4 |
分子量 | 475.32 |
密度 | 1.415±0.06 g/cm3(Predicted) |
沸点 | 644.7±55.0 °C(Predicted) |
溶解度 | 溶于DMSO (高达30 mg/ml) |
酸度系数 | 4.69±0.10(Predicted) |
存储条件 | 2-8°C |
稳定性 | 从提供的购买之日起稳定1年。DMSO中的溶液可以在-20 °C下储存长达3个月。 |
外观 | 粉末 |
颜色 | white to beige |
体外研究 | ML-210 exhibits cell-killing activity across a panel of 821 cancer cell lines (WM88, LOX-IMVI, CJM, U257, CAKI2, A498, HT1080, MC38, PANC02). ML-210 is a prodrug that requires cellular activation to bind GPX4. ML-210 has IC 50 s of 71 nM, 272 nM and 107nM for BJeLR (HRAS V12 ), BJeH-LT (without HRAS V12 ) and DRD cell lines, respectively. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.104 ml | 10.519 ml | 21.038 ml |
5 mM | 0.421 ml | 2.104 ml | 4.208 ml |
10 mM | 0.21 ml | 1.052 ml | 2.104 ml |
5 mM | 0.042 ml | 0.21 ml | 0.421 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!